SEC Form 4Coverage since Jun 11, 2026
$ELV insider trading
Over the last 12 months, Elevance Health insiders reported 2 buys totaling $1.4M and 2 sales totaling $209K across SEC Form 4 filings.
- Bought · 12m
- $1.4M 2 events
- Sold · 12m
- $209K 2 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $ELV · 12Mvia TradingView
Top insiders · 12m
BOUDREAUX GAILPresident and CEO1× · $1.0M
PERU RAMIRO G—1× · $366K
Dixon Robert L JR—1× · $61K
Penczek Ronald WCAO & Controller1× · $149K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | PERU RAMIRO GD | ▲ Buy | 1,000 | $366.05 | $366K | +10.1% | — |
| Jul 17, 2026 | BOUDREAUX GAILPresident and CEO · O·D | ▲ Buy | 2,725 | $367.79 | $1.0M | +1.6% | 2 tranches |
| Jun 12, 2026 | Penczek Ronald WCAO & Controller · O | ▼ Sale | 369 | $403.16 | $149K | -9% | — |
| Jun 11, 2026 | Dixon Robert L JRD | ▼ Sale | 151 | $401.77 | $61K | -1.4% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ELV feed.